Downregulation of long non-coding RNA MT 1 DP correlates with poor prognosis in colorectal cancer

Jun Wang,Lin Chen,Feng Wang,Bo Dai,Yue Li,Yitao Ding

2019-01-01

Abstract:Background: Accumulated evidence has shown that long non-coding RNAs (lncRNAs) are emerging as key molecules in human malignancies. The lncRNA metallothionein 1D, pseudogene (MT1DP) was recently identified as a tumor suppressor in liver cancers. However, its expression pattern and clinical performance in colorectal cancer (CRC) have not been addressed. Methods: Our investigation was carried out on 78 cases of CRC tissues and matched adjacent normal tissues. The expression levels of MT1DP were determined by quantitative real-time PCR. Subsequently, its clinical values in CRC were further evaluated. Results: MT1DP expression was significantly downregulated in 55 of 78 CRC tissues (70.5%, P<0.001). The area under curve (AUC) of the ROC was 0.714; 95% confidence interval (CI) was 0.636-0.783, the sensitivity was 88.46% and the specificity was 51.28%. Moreover, low level of MT1DP expression in CRC was closely correlated with TNM stage (P=0.020) and distant metastasis (P=0.005). In addition, low MT1DP expression had a poorer overall survival (OS) and disease-free survival (DFS) rates in CRC patients (P=0.002 and 0.006, respectively). Additionally, univariate and multivariable Cox regression analyses further identified that downregulated MT1DP might act as an independent prognostic factor for OS and DFS of CRC patients. Conclusions: Low expression of MT1DP is involved in CRC progression and could be a novel biomarker of diagnostic and prognostic evaluation of CRC patients.